Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...

In a recent study published in the journal Nature, a large team of researchers from the United States (U.S.) used single-cell ribonucleic acid (RNA) sequencing combined with high-resolution ...

The film presents a detailed fluorographic study of the normal heart using venous catheterization, showcasing physiological data such as pressure and flow measurements. It illustrates blood flow ...

Senior Lecturer and Clinical Academic in Faculty of Medicine, Health & Life Sciences, Swansea University Mammals, from the mighty blue whale to the tiny shrew, inhabit nearly every corner of our ...

There are limits in applying AI to images of the heart, according to a new study from the Smidt Heart Institute at ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The heart is the central organ of the human circulatory system. Both congenital and acquired structural ...

BOSTON--(BUSINESS WIRE)--Ancora Heart, Inc., a company developing a completely transcatheter device-based therapy to address heart failure (HF), today announced that patients treated with the ...

Peter J. Knight is at the Astbury Centre for Structural Molecular Biology and the School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK. The ...

Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart ...

According to the American College of Cardiology, nearly 6.7 million Americans have heart failure, more than half with preserved ejection fraction. This condition often leads to frequent ...